Suppr超能文献

正常健康对照者和囊性纤维化患者粪便的能量含量。

Energy content of stools in normal healthy controls and patients with cystic fibrosis.

作者信息

Murphy J L, Wootton S A, Bond S A, Jackson A A

机构信息

Department of Human Nutrition, University of Southampton.

出版信息

Arch Dis Child. 1991 Apr;66(4):495-500. doi: 10.1136/adc.66.4.495.

Abstract

Stool energy losses and the sources of energy within the stool were determined in 20 healthy controls and 20 patients with cystic fibrosis while on their habitual pancreatic enzyme replacement treatment. Stool energy losses were equivalent to 3.5% of gross energy intake in healthy children (range 1.3-5.8%). Despite a comparable gross energy intake, stool energy losses were three times greater in patients with cystic fibrosis than controls averaging 10.6% of gross energy intake (range 4.9-19.7%). Stool lipid could account for only 29% and 41% of the energy within the stool in controls and patients with cystic fibrosis respectively and was poorly related to stool energy. Approximately 30% of the energy within the stool could be attributable to colonic bacteria in both the healthy children and patients with cystic fibrosis. These results suggest that stool energy losses in healthy children are relatively modest but that even when patients with cystic fibrosis are symptomatically well controlled on pancreatic enzyme replacement, raised stool energy losses may continue to contribute towards an energy deficit sufficient to limit growth in cystic fibrosis. As the energy content per gram wet weight remains relatively constant (8 kJ/g), stool energy losses may be estimated from simple measurements of stool wet weight.

摘要

在20名健康对照者和20名接受常规胰酶替代治疗的囊性纤维化患者中,测定了粪便能量损失及粪便中的能量来源。健康儿童的粪便能量损失相当于总能量摄入的3.5%(范围为1.3 - 5.8%)。尽管总能量摄入相当,但囊性纤维化患者的粪便能量损失是对照组的三倍,平均占总能量摄入的10.6%(范围为4.9 - 19.7%)。在对照组和囊性纤维化患者中,粪便脂质分别仅占粪便中能量的29%和41%,且与粪便能量关系不大。在健康儿童和囊性纤维化患者中,粪便中约30%的能量可归因于结肠细菌。这些结果表明,健康儿童的粪便能量损失相对较小,但即使囊性纤维化患者在胰酶替代治疗下症状得到良好控制,粪便能量损失增加仍可能导致能量不足,足以限制囊性纤维化患者的生长。由于每克湿重的能量含量相对恒定(8千焦/克),粪便能量损失可通过简单测量粪便湿重进行估算。

相似文献

4
Short-chain fatty acid absorption in patients with cystic fibrosis.囊性纤维化患者对短链脂肪酸的吸收
J Pediatr Gastroenterol Nutr. 1992 Aug;15(2):146-9. doi: 10.1097/00005176-199208000-00008.

引用本文的文献

2
Physiological protection against weight gain: evidence from overfeeding studies and future directions.生理性体重增加保护:过食研究的证据及未来方向。
Philos Trans R Soc Lond B Biol Sci. 2023 Sep 11;378(1885):20220229. doi: 10.1098/rstb.2022.0229. Epub 2023 Jul 24.
3
Drug therapies for reducing gastric acidity in people with cystic fibrosis.用于降低囊性纤维化患者胃酸的药物治疗。
Cochrane Database Syst Rev. 2021 Apr 27;4(4):CD003424. doi: 10.1002/14651858.CD003424.pub5.
4
Proof of concept for identifying cystic fibrosis from perspiration samples.从汗液样本中识别囊性纤维化的概念验证。
Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24408-24412. doi: 10.1073/pnas.1909630116. Epub 2019 Nov 18.
5
Drug therapies for reducing gastric acidity in people with cystic fibrosis.用于降低囊性纤维化患者胃酸的药物疗法。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD003424. doi: 10.1002/14651858.CD003424.pub4.
7
Control of malabsorption in cystic fibrosis.囊性纤维化中吸收不良的控制
Paediatr Drugs. 2000 May-Jun;2(3):205-22. doi: 10.2165/00128072-200002030-00005.
10
Uses and abuses of enzyme therapy in cystic fibrosis.酶疗法在囊性纤维化中的应用与滥用
J R Soc Med. 1998;91 Suppl 34(Suppl 34):2-13. doi: 10.1177/014107689809134s02.

本文引用的文献

1
A ballistic bomb calorimeter.弹道式炸弹量热计。
Br J Nutr. 1959;13:501-8. doi: 10.1079/bjn19590064.
3
The microbial contribution to human faecal mass.微生物对人类粪便量的贡献。
J Med Microbiol. 1980 Feb;13(1):45-56. doi: 10.1099/00222615-13-1-45.
5
On comparing regression lines with unequal slopes.关于比较斜率不等的回归线。
Am J Physiol. 1982 Mar;242(3):R178-80. doi: 10.1152/ajpregu.1982.242.3.R178.
9
Individual dietary surveys: purposes and methods.个体饮食调查:目的与方法。
World Rev Nutr Diet. 1971;13:105-64. doi: 10.1159/000391884.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验